Research map: Genetically proxied glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor pathway modulation is associated with favorable aging phenotypes: a drug-target Mendelian randomization study

Back to the article

Papers in this map

  1. The Hallmarks of Aging · Carlos López-Otı́n · 2013 · 15427 citations · Cited by this paper
  2. Treatment with dapagliflozin and empagliflozin reduces concentrations of N4-acetylcytidine in plasma, a biomarker associated with vascular damage · 2026 · Related
  3. Hallmarks of aging: An expanding universe · Carlos López-Otı́n · 2023 · 6513 citations · Cited by this paper
  4. Associations of cumulative exposure and dynamic trajectories of the cholesterol–HDL–glucose index and its obesity-related derivatives with cardiovascular disease: a nationwide prospective cohort study · 2026 · Related
  5. FinnGen provides genetic insights from a well-phenotyped isolated population · Mitja Kurki · 2023 · 4378 citations · Cited by this paper
  6. Deep learning analysis of ECGs detects Cardiovascular–Kidney–Metabolic syndrome burden in people with diabetes: a report from the Silesia Diabetes-Heart Project · 2026 · Related
  7. A standard procedure for creating a frailty index · Samuel D. Searle · 2008 · 3693 citations · Cited by this paper
  8. Predicting all-cause and cardiovascular mortality in hypertensive patients by combining the CHG index and its obesity indicators: a prospective cohort study with survival prediction model · 2026 · Related
  9. Tirzepatide Once Weekly for the Treatment of Obesity · Ania M. Jastreboff · 2022 · 3661 citations · Cited by this paper
  10. Divergent mitochondrial and fibrotic signatures in atrial fibrillation: insights from organoids and GEO data · 2026 · Related
  11. Frailty in Relation to the Accumulation of Deficits · Kenneth J. Rockwood · 2007 · 3108 citations · Cited by this paper
  12. STIM1-mediated Treg instability in HFpEF: a new immunological target emerges? · 2026 · Related
  13. Geroscience: Linking Aging to Chronic Disease · Brian Keith Kennedy · 2014 · 2846 citations · Cited by this paper
  14. Joint longitudinal trajectories of the triglyceride-glucose index combined with BMI and waist-to-height ratio and incident cardiovascular disease: a prospective cohort study from the English longitudinal study of ageing · 2026 · Related
  15. Meta-analysis of genome-wide association studies for height and body mass index in ∼700000 individuals of European ancestry · Loïc Yengo · 2018 · 2617 citations · Cited by this paper
  16. Predictive significance of triglyceride-glucose index in forecasting adverse cardiovascular events among Type 2 diabetes mellitus patients with co-existing metabolic dysfunction-associated steatotic liver disease (MASLD): evidence from two cohort studies · 2026 · Related
  17. Mendelian randomization · Eleanor C. M. Sanderson · 2022 · 2293 citations · Cited by this paper
  18. Baseline, repeated-measure burden, and two-time-point patterns of the triglyceride-glucose index-visceral lipid ratio (TyG-VLR) and incident cardiovascular disease in cardiovascular-kidney-metabolic (CKM) syndrome stages 0–3: a longitudinal China Health and Retirement Longitudinal Study (CHARLS) analysis · 2026 · Related
  19. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes · Juan P. Frías · 2021 · 2036 citations · Cited by this paper
  20. Associations of insulin resistance-related indices with the risk and progression of cardiometabolic multimorbidity in individuals with metabolic dysfunction-associated steatotic liver disease: a prospective cohort study · 2026 · Related
  21. Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration · Veronika Whitesell Skrivankova · 2021 · 1750 citations · Cited by this paper
  22. Anti-obesity drug discovery: advances and challenges · Timo D. Müller · 2021 · 1011 citations · Cited by this paper
  23. Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging · Elizabeth Helen Blackburn · 2006 · 1009 citations · Cited by this paper
  24. Glucagon-like peptide-1 receptor: mechanisms and advances in therapy · Zhikai Zheng · 2024 · 982 citations · Cited by this paper
  25. Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials · Tina Vilsbøll · 2012 · 978 citations · Cited by this paper
  26. Biomarkers of aging for the identification and evaluation of longevity interventions · Mahdi Moqri · 2023 · 695 citations · Cited by this paper
  27. Genetic drug target validation using Mendelian randomisation · Amand Floriaan Schmidt · 2020 · 638 citations · Cited by this paper
  28. Genetic drivers of heterogeneity in type 2 diabetes pathophysiology · Ken Suzuki · 2024 · 602 citations · Cited by this paper
  29. Combining evidence from Mendelian randomization and colocalization: Review and comparison of approaches · Verena Zuber · 2022 · 584 citations · Cited by this paper
  30. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity · Louis J. Aronne · 2025 · 572 citations · Cited by this paper
  31. Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action · John R. Ussher · 2023 · 566 citations · Cited by this paper
  32. Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program · Anurag Verma · 2024 · 426 citations · Cited by this paper
  33. A meta-analysis of genome-wide association studies identifies multiple longevity genes · Joris Deelen · 2019 · 417 citations · Cited by this paper
  34. Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and Obesity · Daniel J. Drucker · 2024 · 370 citations · Cited by this paper
  35. Proteomic aging clock predicts mortality and risk of common age-related diseases in diverse populations · M. Austin Argentieri · 2024 · 338 citations · Cited by this paper
  36. A genome‐wide association study of the frailty index highlights brain pathways in ageing · Janice L. Atkins · 2021 · 335 citations · Cited by this paper
  37. Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials · Sunil V. Badve · 2024 · 332 citations · Cited by this paper
  38. Abdominal obesity: a marker of ectopic fat accumulation · Ulf Smith · 2015 · 301 citations · Cited by this paper
  39. GIPR agonism mediates weight-independent insulin sensitization by tirzepatide in obese mice · Ricardo J. Samms · 2021 · 247 citations · Cited by this paper

Source: OpenAlex (CC0)